Table 4.
Parameters | Unfavorable Outcome | ||
---|---|---|---|
OR | 95% CI | p | |
Age | 1.031 | 0.991–1.073 | 0.126 |
Hypertension | 1.057 | 0.614–1.818 | 0.842 |
Diabetes mellitus | 1.262 | 0.567–2.809 | 0.569 |
Atrial fibrillation | 1.212 | 0.563–2.608 | 0.623 |
TOAST classification | |||
Large-artery atherosclerosis (reference) | |||
Cardioembolic | 1.265 | 0.537–2.980 | 0.591 |
Undetermined or others | 1.681 | 0.602–2.691 | 0.322 |
Occlusion site, n (%) | |||
ICA (reference) | |||
MCA | 0.651 | 0.384–1.105 | 0.112 |
Baseline NIHSS score | 1.097 | 1.028–1.172 | 0.005 |
Baseline ASPECT score | 0.761 | 0.631–0.919 | 0.004 |
Collateral circulation | |||
Grade 0 (reference) | |||
Grade 1 | 0.180 | 0.068–0.477 | 0.001 |
Grade 2 | 0.116 | 0.045–0.303 | < 0.001 |
mTICI, 2b/3 | 0.430 | 0.219–0.845 | 0.014 |
FBG (mmol/L) | 1.242 | 1.096–1.407 | 0.001 |
Abbreviations: ASPECT, Alberta Stroke Program Early CT; CI, confidence interval; FBG, fasting blood-glucose; ICA, internal carotid artery; MCA, middle carotid artery; mTICI, modified thrombolysis in cerebral infarction; NIHSS, National Institutes of Health Stroke Scale; OR, odds ratio; TOAST, the Trial of ORG 10172 in Acute Stroke Treatment.